Close×

Coffee pod manufacturer iCapsulate is in voluntary administration, less than two years after receiving a $2.5m investment offer in the biggest ever deal seen on TV show Shark Tank.

Based in Blacktown, NSW, the company has the capacity to make two million capsules a day, and has a daily roasting capacity of ten tonnes.

According to the administrator Rodgers Reidy iCapsulate is solvent, with the VA coming as a result of a dispute between shareholders and directors. The administrator is looking for offers for the business as a going concern, both external and internal.

The company has been mired in controversy since the Shark Tank appearance, with rival operators rasing major questions over claims made by founder Kane Bodian on the show that he had contracts with many leading coffee operators in Australia and New Zealand.

Andrew Banks, the Shark Tank investor then withdrew his offer – which would have given him a 22.5 per cent stake in the company – after a year of due diligence, with Banks pointing to what he said were inaccuracies over the biodegradable claims made for the capsules, while Bodian remained adamant that the environmental credentials were certified.

When he was on the Shark Tank Bodian said sales for 2016 were at $4m. According to Banks revenues at iCapsulate were approaching $15m when he withdrew, and heading for $21m next year.

Food & Drink Business

Western Australian producer, Brownes Dairy, has been put up for sale according to the Australian Financial Review (AFR), as one of its biggest lenders, China Mengniu Dairy, calls in its $200 million loan. A reduced demand for milk in China and the current positioning of the global market could be driving the decision.

The Central Coast is about to receive a boost to its local food and beverage manufacturing industry, with construction starting on the $17.14 million Food Manufacturing Innovation Hub, funded by the federal government’s National Reconstruction Fund (NFR).

The Australian Industry Group (Ai Group) says Australia is at a “critical crossroads” when it comes to R&D and decades of rhetoric have not delivered material change.